Hata Yoshio | Clinical Development Institute Banyu Pharmaceutical Co. Ltd.
スポンサーリンク
概要
Clinical Development Institute Banyu Pharmaceutical Co. Ltd. | 論文
- Therapeutic effects of alendronate 35mg once weekly and 5mg once daily in Japanese patients with osteoporosis : a double-blind, randomized study
- Antihypertensive Efficacy and Safety of Fixed-Dose Combination Therapy with Losartan plus Hydrochlorothiazide in Japanese Patients with Essential Hypertension
- Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats
- Predictors of In-Hospital Prognosis After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction Requiring Mechanical Support Devices
- Prevalence of Changes in Undiagnosed Glucose Intolerance According to Age and Gender in Japanese Middle-Aged Working People